Antioxidants as a Bio-shield Against Radiological Weapons

作者: Kedar N. Prasad

DOI: 10.1007/978-94-007-6513-9_2

关键词:

摘要: There are two types of radiological weapon, “dirty bomb,” and nuclear weapon (atom bomb). A dirty bomb can be made from one or more commercially available radioactive isotopes it detonated using a conventional explosive, whereas an atom consists fissionable element, requires complex procedures for detonation. Explosion cause few injuries to mass casualties, depending upon the type increase chronic health risks among survivors. Bio-Shield refers chemicals biologics that prevent mitigate radiation injury when administered before and/or after irradiation. During past decades, several preventive mitigating agents been identified. They grouped into following categories: (a) not approved by FDA, (b) drugs FDA other conditions, (c) certain (d) antioxidants herbs requiring approval. An effective bio-shield recommended humans must satisfy three criteria: (1) should damage in laboratory experiments irradiation; (2) they show at least some evidence humans; (3) doses safe human on short- long-term basis. Published data most preventing chemicals, only first criterion bio-shield, all three.

参考文章(52)
J Laakso, K Jaakkola, E Harju, K Mahlberg, H Tykkä, P Lähteenmäki, Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Research. ,vol. 12, pp. 599- 606 ,(1992)
Brignall Ms, Lamson Dw, Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Alternative medicine review : a journal of clinical therapeutic. ,vol. 4, pp. 304- ,(1999)
Kedar N. Prasad, Handbook of radiobiology ,(1995)
Yih Lin Chung, Lin-Fen Yao, Ae-June Wang, Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy Molecular Cancer Therapeutics. ,vol. 3, pp. 317- 325 ,(2004)
Christian Ostrau, Johannes Hülsenbeck, Melanie Herzog, Arno Schad, Michael Torzewski, Karl J. Lackner, Gerhard Fritz, Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiotherapy and Oncology. ,vol. 92, pp. 492- 499 ,(2009) , 10.1016/J.RADONC.2009.06.020
C. Borek, A. Ong, H. Mason, L. Donahue, J. E. Biaglow, Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 1490- 1494 ,(1986) , 10.1073/PNAS.83.5.1490
Ibrahim Kocer, Seyithan Taysi, Mustafa Vecdi Ertekin, Ihsan Karslioglu, Akcahan Gepdiremen, Orhan Sezen, Korkmaz Serifoglu, The effect of L-carnitine in the prevention of ionizing radiation-induced cataracts: a rat model. Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 245, pp. 588- 594 ,(2007) , 10.1007/S00417-005-0097-1
A. Ben-Amotz, Shaul Yatziv, Mordechai Sela, Simon Greenberg, Boris Rachmilevich, Masha Shwarzman, Ze'ev Weshler, Effect of natural beta-carotene supplementation in children exposed to radiation from the Chernobyl accident. Radiation and Environmental Biophysics. ,vol. 37, pp. 187- 193 ,(1998) , 10.1007/S004110050116
Junru Wang, Marjan Boerma, Qiang Fu, Ashwini Kulkarni, Louis M. Fink, Martin Hauer-Jensen, Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism. International Journal of Radiation Oncology Biology Physics. ,vol. 68, pp. 1483- 1490 ,(2007) , 10.1016/J.IJROBP.2007.03.036